To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Collaboration

iCAN Research and Advocacy Summit #IRL

Editor's note: I'm excited to bring this blog to you in collaboration with my colleague Mary Short, a Research Advisor for Pediatric Capabilities and co-chair of the Pediatric Steering Committee at Lilly.

There are no voices too young to make a positive impact on clinical research. That's why attending the annual iCAN Research & Advocacy Summit has been a highlight of our summer for the past two years. iCAN Research is a global consortium of Youth Advisory Groups (YAGs) working to provide a voice for children and families in pediatric medicine, research and innovation. The annual summit brings people of diverse ages, global perspectives and health care experience levels together for a week under one roof—this year in Edinburgh, Scotland.

Our time spent at the summit was full of interesting, innovative and thought-inspiring presentations led by youth advisers, clinicians and industry leaders. Here, we spotlight just a few of the themes that emerged during the event.

Digital Health
Apps. In one word, this is how we would summarize the clinical research presentations led by the youth leaders. At the start of the week-long summit, each team of YAGs was given an assignment to design a clinical trial. With an assigned condition, such as psoriasis or Crohn's disease, and just a few key details to get them started, they were instructed to determine the trial design, dosing schedule and patient information sheet. Though it wasn't a requirement of the exercise, nearly every team assumed their study would have an app to help with solutions like better managing study visit appointments or serving as an e-diary. The industry leaders in the room considered the tension between the relatively slow research cycle compared with the fast pace of advancing digital health technology and wondered about these digital natives who expect what we consider cutting-edge to be a basic offering. Digital health in clinical research is both a challenge and an opportunity!

Ethics
A hot topic, and rightfully so, during the summit was ethics. Dr. Bob Phillips (Clinical Academic at CRD and Honorary Consultant in Paediatric/Teenage-Young Adult Oncology at Leeds Children’s Hospital) made the ethical principles come to life by linking important questions to unique and funny research examples to determine if the research was ethical. For example, to demonstrate selection bias, he displayed an image of a cat then asked two attendees if they owned a cat. Both did, and Dr. Phillips proclaimed therefore that everyone owned a cat. He then asked all attendees if they had a pet cat. As attendees raised their hands in response, he adjusted his assumption to say that 50% of all people owned a cat. That interaction led to a discussion of representative samples and the ability (or not) to generalize research findings. An image of a hedgehog as “road kill” was used to pose questions related to trial risk and if the use of placebo was ethical. His presentation had everyone laughing but also made a complicated and rather serious topic understandable and memorable. Attendees representing industry and academia agreed that this was the most fun and informative ethics presentation they’ve attended.

Connections and Community #IRL
The global nature of the iCAN community often means that iCAN members and supporters meet each other in real life (#IRL) for the first time at the annual summit. We personally had a few #IRL moments with some of our digital friends, but we also saw others having this same experience.

It was particularly heartwarming to see the outpouring of love and support for an iCAN youth member who wasn't able to travel to the summit. Whether near or far, iCAN is truly an inclusive community that values all voices.

We want to thank iCAN Research and all the youth advisors and family members who made this year's summit so powerful—we certainly have a lot to think about and are looking forward to next year's event in Kansas City!

Blog post originally appeared on LillyPad.

Tags: iCAN, Pediatric Research,

Recent Articles

From Alzheimer’s Diagnosis to Advocate

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
January 31st, 20225 minute read

Geri had been involved in research in addition to having a healthcare background. Because of this, after being diagnosed with Alzheimer's she knew that she wanted to participate in a clinical trial.

Committed to Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 24th, 20211 minute read

Lilly has a strong legacy in cancer research. Our dedicated oncology team work together to create medicines that make life better for people around the world.

Proud Partners in Breast Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 22nd, 20213 minute read

Lilly is proud to foster true partnerships with external stakeholders. By working together to raise awareness of breast cancer research, we can make life better for people around the world.

Recommendations for Decentralized Clinical Trial Capabilities in the Wake of COVID-19

BlogAuthors_Kevin_2Feb2022
Kevin Hudziak
September 15th, 20214 minute read

Tips to implement an effective and successful decentralized clinical trial for multiple touch points.

The COVID-19 Pandemic Changed How Sites Conduct Clinical Trials Forever

BlogAuthors_Kevin_2Feb2022
Kevin Hudziak
July 29th, 20213 minute read

To better understand how various countries adapted to execute clinical trials during a pandemic, we conducted a series of virtual feedback sessions with clinicians from all over the world.

This site is intended for US residents.
This site is intended for US residents.